Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
14
pubmed:dateCreated
1996-8-7
pubmed:abstractText
Arrest of the cell cycle in G2 phase following DNA damage helps protect cell viability by allowing time for DNA repair before entry into mitosis (M phase). Abrogation of G2 arrest sensitizes cells to the effects of DNA-damaging agents. UCN-01 (7-hydroxystaurosporine), a protein kinase C inhibitor that may block G2 checkpoint regulation, has been reported to enhance the cytotoxicity of mitomycin C, a known DNA-damaging agent.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0027-8874
pubmed:author
pubmed:issnType
Print
pubmed:day
17
pubmed:volume
88
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
956-65
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:8667426-Alkaloids, pubmed-meshheading:8667426-Antineoplastic Agents, pubmed-meshheading:8667426-Burkitt Lymphoma, pubmed-meshheading:8667426-CDC2 Protein Kinase, pubmed-meshheading:8667426-Cell Division, pubmed-meshheading:8667426-Cell Survival, pubmed-meshheading:8667426-Cisplatin, pubmed-meshheading:8667426-Colonic Neoplasms, pubmed-meshheading:8667426-Cyclin B, pubmed-meshheading:8667426-Cyclin B1, pubmed-meshheading:8667426-Cyclins, pubmed-meshheading:8667426-Drug Synergism, pubmed-meshheading:8667426-Flow Cytometry, pubmed-meshheading:8667426-G2 Phase, pubmed-meshheading:8667426-Gamma Rays, pubmed-meshheading:8667426-Genes, p53, pubmed-meshheading:8667426-Humans, pubmed-meshheading:8667426-Immunoblotting, pubmed-meshheading:8667426-Mitotic Index, pubmed-meshheading:8667426-Mutation, pubmed-meshheading:8667426-Precipitin Tests, pubmed-meshheading:8667426-Radiation Dosage, pubmed-meshheading:8667426-Staurosporine, pubmed-meshheading:8667426-Tumor Cells, Cultured
pubmed:year
1996
pubmed:articleTitle
UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53.
pubmed:affiliation
Laboratory of Biological Chemistry, Division of Basic Science, National Cancer Institute, Bethesda, MD, USA.
pubmed:publicationType
Journal Article